Hematology NewsTyrosine kinase inhibitors may boost cardiac risk in chronic myeloid leukemiaJune 13, 2016ThrombosisCMLLeukemia, Myelodysplasia, Transplantation
Hematology TimesMost CML patients who stop nilotinib stay in remissionJune 13, 2016Leukemia, Myelodysplasia, TransplantationCML
Hematology TimesInotuzumab bests standard of care in adult ALLJune 13, 2016Leukemia, Myelodysplasia, TransplantationALL
Hematology TimesTeam discovers 2 new subtypes of pediatric BCP ALLJune 11, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesBrain changes in pediatric ALL associated with methotrexateJune 10, 2016Leukemia, Myelodysplasia, TransplantationPediatricsALL
Hematology TimesVenetoclax + LDAC has potential in older AML patientsJune 9, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology NewsMaintenance rituximab extends progression-free but not overall survival in CLLJune 8, 2016CLLLeukemia, Myelodysplasia, Transplantation
Hematology TimesRituximab plus chemo in kids with B-NHL could be practice changingJune 8, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatricsNon-Hodgkin Lymphoma
Hematology TimesHispanic, black AYA more likely to die of their cancerJune 7, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPediatrics
Hematology NewsVIDEO: CPX-351 ‘new standard of care’ for older patients with secondary AMLJune 6, 2016AMLLeukemia, Myelodysplasia, TransplantationRare Diseases
Hematology TimesEC broadens indication for ibrutinibJune 6, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersNon-Hodgkin Lymphoma
Hematology TimesIngredient in aspirin may help fight leukemiaJune 4, 2016Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesAYAs still fare worse than kids with leukemia, lymphomaMay 31, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersAMLALLHodgkin LymphomaNon-Hodgkin Lymphoma
Oncology PracticeOld theories spark new ideas about cancer cell metabolismMay 27, 2016Leukemia, Myelodysplasia, Transplantation
Hematology NewsVenetoclax achieves responses in CLL refractory to ibrutinib, idelalisibMay 26, 2016CLLLeukemia, Myelodysplasia, Transplantation
